Atul Ltd Announces Senior Management Change with Dr Anuj Mittal as New President Research

1 min read Updated on 23 Feb 2026, 04:32 PM

Reviewed by

Ashish TScanX News Team

Overview

Atul Ltd has appointed Dr Anuj Mittal as President Research effective February 23, 2026, replacing retired Dr Uday Bapat. Dr Mittal brings 30 years of experience in R&D capabilities, process innovation and commercialisation, along with educational qualifications including a postgraduate degree in science and doctoral degree in Organic Chemistry. The company announced this senior management change to BSE and NSE under Regulation 30 compliance requirements.

*this image is generated using AI for illustrative purposes only.

Atul Ltd has announced a significant change in its senior management team with the appointment of Dr Anuj Mittal as President Research, effective February 23, 2026. The company communicated this development to both BSE and NSE under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Management Transition Details

The leadership change involves Dr Anuj Mittal taking over the President Research position from Dr Uday Bapat, who has retired from the role. This transition marks Dr Mittal's entry into the company's senior management team as of February 23, 2026.

Parameter	Details
Reason for Change	Dr Uday Bapat retired; Dr Anuj Mittal took over
Effective Date	February 23, 2026
Position	President, Research
Management Level	Senior management team member

New Appointee Profile

Dr Anuj Mittal brings substantial expertise to his new role at Atul Ltd. His professional background spans three decades in the research and development sector, with particular focus on building R&D capabilities, process innovation, and commercialisation activities.

Educational Qualifications

Postgraduate degree in science
Doctoral degree in Organic Chemistry
30 years of experience in research and development

Regulatory Compliance

The announcement was made in compliance with regulatory requirements, with the company informing both major stock exchanges through their respective portals. Atul Ltd trades on BSE with scrip code 500027 and on NSE under the symbol ATUL. The disclosure was signed by Lalit Patni, Company Secretary and Chief Compliance Officer, ensuring proper adherence to listing obligations and disclosure requirements.

ATUL Limited Posts 47% Growth in Q3 Consolidated Net Profit to ₹1.60 Billion

1 min read Updated on 23 Jan 2026, 02:45 PM

Reviewed by

Shriram SScanX News Team

Add as a preferred
source on Google

Overview

ATUL Limited reported impressive Q3 results with consolidated net profit surging 46.79% year-on-year to ₹1.60 billion from ₹1.09 billion. The strong performance demonstrates the specialty chemicals and pharmaceutical company's operational excellence and ability to generate robust returns while maintaining growth momentum across its business segments.

*this image is generated using AI for illustrative purposes only.

ATUL Limited has reported strong financial results for the third quarter, with consolidated net profit showing significant improvement compared to the same period in the previous year. The specialty chemicals and pharmaceutical company delivered robust performance across its business operations during the quarter.

Financial Performance Highlights

The company's consolidated net profit for Q3 reached ₹1.60 billion, representing a substantial increase from ₹1.09 billion recorded in the corresponding quarter of the previous year. This performance demonstrates the company's ability to generate strong returns and maintain growth momentum.

Financial Metric:	Q3 Current Year	Q3 Previous Year	Growth (%)
Consolidated Net Profit:	₹1.60 billion	₹1.09 billion	+46.79%

Business Performance Analysis

The year-on-year growth of 46.79% in consolidated net profit indicates strong operational performance and effective business execution by ATUL Limited during the quarter. This significant improvement in profitability reflects the company's continued focus on delivering value to stakeholders.

The substantial increase in net profit demonstrates ATUL Limited's resilience and ability to capitalize on market opportunities while maintaining operational efficiency. The company's performance in Q3 shows positive momentum in its core business segments.

Market Position

ATUL Limited's strong quarterly results reinforce its position as a significant player in the specialty chemicals and pharmaceutical sectors. The company's ability to deliver consistent growth in profitability highlights its competitive strengths and market positioning.

The robust financial performance in Q3 reflects ATUL Limited's strategic initiatives and operational excellence, positioning the company well for continued growth and value creation for its stakeholders.